B3GAT1 and Lyme disease: In agreement with this article, many authorities such as the CDC [97], North American medical experts [98], European science organizations [99], and the Royal College of Pathologists of Australasia [100] have explicitly warned against the use of CD57 and other unvalidated tests in the diagnosis of Lyme disease.